|1.||Hurrell, Richard F: 2 articles (01/2015 - 11/2009)|
|2.||Zimmermann, Michael B: 2 articles (01/2015 - 11/2009)|
|3.||Wegmüller, Rita: 1 article (01/2015)|
|4.||Utzinger, Jürg: 1 article (01/2015)|
|5.||Diakité, Victorine G: 1 article (01/2015)|
|6.||Glinz, Dominik: 1 article (01/2015)|
|7.||Seifert, Burkhardt: 1 article (01/2015)|
|8.||Brittenham, Gary M: 1 article (01/2015)|
|9.||N'Goran, Eliézer K: 1 article (01/2015)|
|10.||Ouattara, Mamadou: 1 article (01/2015)|
|1.||Iron-Deficiency Anemia (Anemia, Iron Deficiency)
03/01/2013 - "Iontophoretic mediated transdermal delivery of ferric pyrophosphate (FPP) in combination with microneedle pretreatment was investigated as a potential treatment for iron deficiency anemia (IDA). "
11/01/2009 - "In the first study, young women (n = 98) with an iron status varying from iron deficiency anemia to iron sufficiency (women with serum ferritin concentrations 25-40 microg/L were not included) were given stable isotope-labeled test meals (n = 196) containing ferrous sulfate, ferrous fumarate, or ferric pyrophosphate, after which plasma hepcidin and iron bioavailability were measured. "
01/01/2015 - "The study groups were: group 1: normal diet and IPT-placebo (n = 125); group 2: consumption of porridge, an iron-fortified complementary food (CF) with optimised composition providing 2 mg iron as NaFeEDTA and 3.8 mg iron as ferrous fumarate 6 days per week (CF-FeFum) and IPT-placebo (n = 126); group 3: IPT of malaria at 3-month intervals, using sulfadoxine-pyrimethamine and amodiaquine and no dietary intervention (n = 127); group 4: both CF-FeFum and IPT (n = 124); and group 5: consumption of porridge, an iron-fortified CF with the composition currently on the Ivorian market providing 2 mg iron as NaFeEDTA and 3.8 mg iron as ferric pyrophosphate 6 days per week (CF-FePP) and IPT-placebo (n = 127). "
01/01/2012 - "74 childbearing age women aged 21 to 45 years with anemia were randomly assigned to intervention or control group by hemoglobin content, and a iron nutrition packet (mainly composed of ferric pyrophosphate and ferrous fumarate, containing iron 8 mg) or a placebo packet was given daily for six months, respectively. "
|2.||ferrous fumarate (fumar)